NCT05141968View on ClinicalTrials.gov

Vitamin D Supplementation and Glycemic Control Improvement Among Type 1 Diabetic Children

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

January 1, 2018

Study Completion Date

June 16, 2021

Conditions
Type 1 Diabetes MellitusVitamin D Deficiency
Interventions
DIETARY_SUPPLEMENT

vitamin D supplements (2000 IU/day)

The interventional (experimental) group received vitamin D supplements (2000 IU/day). According to previous studies and after the direct supervision from the treating pediatrician and endocrinologist, the best preparation and dosage of vitamin D was used (According to FDA the recommended dose for children age 1 year and older is 2,000 IU/day).

Trial Locations (1)

79702

Al-Rantisi pediatric hospital, Gaza

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT05141968 - Vitamin D Supplementation and Glycemic Control Improvement Among Type 1 Diabetic Children | Biotech Hunter | Biotech Hunter